Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $185,679 - $217,103
-2,490 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $82,548 - $93,559
-1,119 Reduced 31.01%
2,490 $200,000
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $12,719 - $13,905
-158 Reduced 4.19%
3,609 $291,000
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $665,422 - $749,493
-8,712 Reduced 69.81%
3,767 $318,000
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $133,138 - $145,447
-1,766 Reduced 12.4%
12,479 $1 Million
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $490,189 - $567,788
-6,258 Reduced 30.52%
14,245 $1.15 Million
Q2 2020

Aug 13, 2020

SELL
$78.66 - $94.14 $256,667 - $307,178
-3,263 Reduced 13.73%
20,503 $1.77 Million
Q1 2020

May 14, 2020

BUY
$71.57 - $93.3 $221,795 - $289,136
3,099 Added 14.99%
23,766 $1.93 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $61,360 - $70,760
800 Added 4.03%
20,667 $1.73 Million
Q3 2019

Nov 13, 2019

BUY
$81.4 - $89.78 $161,986 - $178,662
1,990 Added 11.13%
19,867 $1.74 Million
Q2 2019

Aug 14, 2019

BUY
$73.44 - $82.41 $2,717 - $3,049
37 Added 0.21%
17,877 $1.46 Million
Q1 2019

May 14, 2019

SELL
$64.48 - $81.31 $75,441 - $95,132
-1,170 Reduced 6.15%
17,840 $1.45 Million
Q4 2018

Feb 12, 2019

BUY
$61.45 - $77.8 $145,022 - $183,608
2,360 Added 14.17%
19,010 $1.25 Million
Q3 2018

Nov 13, 2018

BUY
$70.71 - $77.75 $940,442 - $1.03 Million
13,300 Added 397.01%
16,650 $1.28 Million
Q2 2018

Aug 13, 2018

BUY
$63.43 - $75.41 $212,490 - $252,623
3,350 New
3,350 $247,000
Q1 2018

May 14, 2018

SELL
$62.56 - $72.26 $262,752 - $303,492
-4,200 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $249,900 - $271,362
4,200
4,200 $264,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Meiji Yasuda Life Insurance CO Portfolio

Follow Meiji Yasuda Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.